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The feasibility of outpatient elecrophysiologic testing was
examined by reviewing 100 consecutive outpatient tests
performed in 95 patients. Seventy-one of the patients (75%)
had no underlying heart disease. The electrophysiologic
tests were performed to evaluate supraventricutar tachy-
eardias in = 47), nonsustained ventricular tachycardia In
= 20), unexplained syncope (n = 21), palpitation (n = 9) or
intermittent heart block in = 2). A mean of 2.8
._ 0
.5 6c
electrode catheters were inserted through a femoral vein .
An electrode catheter was inserted into a suhdavian or
internal jugular vein in 28 tests and a 5F cannula was
inserted into a femoral artery to monitor the blood pressure
In 20 tests. The results of 61 tests (61%) were abnormal .
Patients were monitored for a mean of 3.8 ± 1 .2 6 after the
Flectrophysiologic testing has played a major role in recent
years in the management of supraventricular and ventricular
tachycardias (1,2) . Standard clinical practice has involved
hospitalization of patients usually beginning the day before
the procedure (3) . However, many patients who undergo
electrophysiologic testing do not have life-threatening ar-
rhythmias (4) and could potentially undergo electrophysio-
logic testing on an outpatient basis . We have performed
electrophysiologic tests in such patients in an outpatient
setting and the purpose of this study was to compare the cost
and results of outpatient testing with those of inpatient
electrophysiologic testing in matched groups of patients .
Methods
Study design. Ninety-five patients who underwent 100
consecutive outpatient electrophysiologic tests in 1988
formed the outpatient study group . To compare the costs
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procedure and then discharged . No complications so-
rtrod .
u F(,r cost .analysis a subgroup of 60 of these patients was
matched trr age, gender, heart disease and indication for
elrrtrophysiotogic testing with a group of 60 patients who
underwent electrophysiologic testing as inpatients . Physi-
cians' fees for the two groups were similar ; however, the
mean hospital charge was 55,845 ± 3,763 for the inpatient
group compared with only $2,120 ± 1,244 for the outpa-
tient group (p < 0 .001) . Thus, oulpatientelectrophysiologic
testing is feasible and safe and results in substantial cost
savings in patients without fife-threatening arrhylhmias.
(J Am Colt Cardof 1940;16:1415-0)
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and complications of inpatient and outpatient electrophysi-
ologic testing, an attempt was made to match the patients
who underwent outpatient electrophysiologic testing with a
cohort of patients who were hospitalized at the time of their
electrophysiologic test in 1986 or 1987 . The inpatients and
outpatients were matched for age, gender, heart disease and
indication for electrophysiologic testing . Sixty patients were
appropriately matched and the cost analysis was performed
on these patients .
Electrophysiologic testing protocol . Electrophysiologic
tests were performed when patients were fasting and not
sedated. The skin was anesthetized with 2% lidocaine
. One
to four 6F quadripolar catheters were introduced through a
7F sheath into a femoral and a subclavian or internal jugular
vein and positioned in the heart under fluoroscopic guidance .
The heart was paced at twice late diastolic threshold using a
Bloom DTU 201 stimulator and isolation unit (Bloom).
Electrograms were amplified, displayed and recorded with
use of a Siemens Mingograf 7 system . A 5F cannula was
introduced into a femoral artery as clinically indicated to
monitor blood pressure .
Outpatient study protocol . All patients who were not
hospitalized at the time of their referral were considered for
outpatient electrophysiologic testing . Patients who might
undergo an additional procedure such as catheter or surgical
0735-1097/90153.50
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ablation or who had a high probability of inducible sustained
ventricular tachycardia were not studied as outpatients .
When patients arrived in the electrophysiology laboratory
on the morning of the procedure, a history was obtained and
a physical examination performed
. Laboratory values were
available from the prehospital evaluation by the referring
physician and blood tests were not performed unless the
patient had been treated with warfarin . The patients then
underwent electrophysiologic testing, as described previ-
ously
. After the procedure patients were monitored in a
recovery area for approximately 3 h if only venous access
had been used and for approximately 6 h if an arterial
cannula had been placed . Data on the actual amount of time
of monitoring are presented in Results .
If a patient was treated with an antiarrhythmic agent after
the initial electrophysiologic test, he or she was scheduled
for a follow-up office visit or follow-up outpatient electro-
physiologic testing, as clinically appropriate .
Cast analysis. The total cost of electrophysiologic testing
was calculated by combining physicians' fees and hospital
charges. The hospital billing office provided the total hospital
bill that each patient received . This included room charges,
use of the electrophysiology laboratory, recovery room,
chest roentgenograms and blood tests . The University of
Michigan Internal Medicine Associates provided data re-
garding the physicians' fees .
Several inpatients underwent more than one electrophys-
iologic lest during hospitalization. Only the cost of the initial
diagnostic procedure was included . However, the cost of
hospitalization during drug loading before the follow-up
electrophysiologic study was included because such drug
administration was performed on outpatients in the group
that underwent outpatient electrophysiologic testing .
Data are presented in terms of 1988 dollars and are
adjusted for inflation in health care costs, as previously
described (5). The hospital charges were adjusted to reflect
the annual inflation rate for salaries and commodities at the
University of Michigan Medical Center. The inflation factor
for physicians' fees was calculated from the Consumer Price
Index (6) . The inflation factors were a 5
.8% and 5 .6%
increase in hospital charges in 1986 and 1987, respectively,
and a 7 .1% and 7.4% increase in physicians' fees in 1986 and
1987, respectively.
Patient interviews . All patients in the matched cohort
portion of the study were contacted by a physician or
research nurse . The telephone interview was conducted 6 to
30 months after the procedure . The interview consisted of
two questions
: 1) In your mind, were there any difficulties
with the procedure
; if so, what were they? 2) Would you
have preferred being an inpatient or an outpatient?
Data analysis . Data are expressed as mean values ± SD .
Categoric variables in inpatient aad outpatient groups wrre
compared using a chi-square analysis
. Continuous variables
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Table L Clinical Characteristics of 95 Patients Undergoing 100
Outpatient Electrophysiologic Tests
F = female ; M = male; NYHA = New York Heart Association.
were compared using an unpaired a test . A p value < 0.05
was considered significant .
Results
Outpatient Studies
Patient characteristics (Table 1) and indications for testing
.
Ninety-five patients underwent 100 outpatient electrophysi-
ologic studies . Most patients had no structural heart disease.
Indications for electrophysiologic testing consisted of symp-
tomatic nonsustained ventricular tachycardia (n = 17), drug-
resistant supraventricular tachycardia (n = 20), intermittent
heart block (n = 2), drug follow-up for sustained ventricular
tachycardia (n = 4), unexplained syncope (n = 21), disabling
palpitation (n = 9), symptomatic Wolff Parkinson-White
syndrome (n = 23) and cardioversion of atria) flutter (n = 4).
Eighteen patients (4 with ventricular tachycardia and 14 with
supraventricular tachycardia) were undergoing follow-up
electrophysiologic tests for assessment of drug efficacy after
an initial inpatient electrophysiologic test . The patients with
sustained ventricular tachycardia were undergoing a fol-
low-up study after 3 months of antiodarone therapy (7).
Test procedures. A mean of 2.8 ± 0 .5 (range I to 3)
femoral venous sheaths were inserted . Of the 100 tests, 20
involved the use of an arterial cannula, 17 a subclavian vein
sheath and I I
an internal jugular sheath. Seventy-six pa-
tients received 2,000 to 3,000 U of heparin ; in 52 tests
isoproterenol was infused for diagnostic purposes . Nineteen
patients underwent drug testing during the study, 8 with
procainamide and I I with verapamil . Four patients required
electrical cardioversion during the procedure, two for atrial
fibrillation and two for ventricular fibrillation .
Results of testing. Thirty-nine patients had a normal
result on their electrophysiologic study ; five of these were
patients who underwent follow-up electrophysiologic drug
tests . Among the 61 patients with an abnormal test result 3
Age lyrl
46! It
Gender 51 male, 44 female
Heart disease (noo of patients)
No samoturul heats disease 71
Coronary artery disease 14
Dilated cardiomyopathy
3
Valvular heart disease 5
Hypenraphic eardiomyopathy I
Altial septa) derms I
NYHA functional class Inn . of
patients)
l 79
II 14
111 2
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were patients treated with amiadarone for ventricular tachy .
cardia who had inducible, uniform sustained ventricular
tachyeardia that was well tolerated hemodynamically . Fifty-
one patients had inducible paroxysmal supraventricular
tachyeardia, of whom 28 had orthodromic atrioventricular
reentrant tachycardia, 15 atrioventricular node reentry . 3
atria] flutter and 5 intraatrial reentrant tachycardia. One
patient had an abnormal sinus node recovery time and six
had inducible atrial fibrillation that reproduced their clinical
symptoms .
Post-procedure monitoring . Patients were monitored for
a mean of 3 .8 ± 1 .2 h after the procedure . There were no
complications . On the basis of the results of electrophysio-
logic testing, 31 patients were believed not to require any
treatment, 13 patients continued to receive the drug therapy
that had been tested, 45 received new drug therapy, I had a
pacemaker implanted and 10 were referred to :, antiarhyth-
mie surgery. Among patients who were given new drug
therapy after electrophysiologic testing, 12 received a beta-
adrenergic blocking agent, 12 a class la antiarrhythmic
agent, 13 a class Ic antiarrhythmic agent . 6 verapamil and 2
amiodarone . The 25 patients who were initially treated with
a class I antiarrhythmic agent as outpatients all had su-
praventricular tachyeardia and normal or near normal ven-
tricular function . Overall, 69% of the patients received new
therapy or had current therapy confirmed as effective as a
result of outpatient electrophysiologic testing .
Comparison of Inpatient and Outpatient Groups
Group characteristics (Table 2) . The outpatient group
used for the retrospective cohort analysis consisted of a
subgroup of 60 of the 100 patients described previously .
Because of the matched cohort design, demographic char-
acteristics and indications for electrophysiologic testing
were similar for the inpatient and outpatient groups, partic-
ularly in the number and type of catheters inserted and
additional drugs administered during electrophysiologic test-
ing except for the use of an arterial line in a higher percent-
age of inpatients (Table 3)
. Inpatients were hospitalized for a
mean of 3
.7 ± 1 .7 days.
Complications . Two complications occurred in the inpa-
tient group: one pneumothorax and one instance of he-
matoma formation 12 h after the procedure . One outpatient
reported 24 h of tingling in the leg with subsequent resolu-
tion
. Only 7 (12%) of the 60 outpatients would have preferred
hospitalization ; however, only 18 (30%) of the 60 inpatients
would have preferred an outpatient study .
Comparative costs. Outpatient electrophysiologic tests
were associated with a lowercost (Fig . I)
. The mean hospital
charge for the inpatient group was $5,845 ± 3,763 per patient
versus $2,120 x 1,244 for the outpatient group (p < 0 .001) .
After adjusting for inflation, physicians' charges for the two
groups differed by a mean of only $40 ($3,280 t 450 for the
CAD = caronsy artery disease : CM = dilated uardiomyepalhy: CSH =
'amnd sinus hypersensitivity ; EPST = electrophysiologic rusting ; F =
female:51 male.NSVT=nonsuelainedv,,no,,uIrtachy,,ardi,I :SSS=sick
sinus syndrome . SVT = supravemricular tachyeardia : VT = venlriculae
lachyeanl :s WP3v - WoIlf-Parkinson-White syndrome .
outpatient group and $3
.320
.
802 for the inpatient group)
.
The mean overall charge for the outpatient group was $3,685
per patient lower than for the inpatient group .
Discussion
We have demonstrated that outpatient electrophysiologic
testing is feasible and safe, results in significant cost savings
and meets with patient acceptance in patients who do not
have life-threatening arrhythmias . More than 60% of the
Table 3. Electrophysiologic Testing Procedures in Inpatiem and
Outpatient Groups
Inpatient Gmup
	
Outpatient Group
-P < 0.001 versus inpatient group. It =
imemal juWtar vain; SC -
subclanan vem.
in 60) (n=601
Mean no. of remora) 2.7 0 .5 2 .9 x 0.3
sheath,
Anedsl line cannula
37 (65%) 14(237,)-
SC or Il sheah 20(33(3)
14(23%)
Isoprmerenol administered 35,58%)
33 (55/I
Electrical curdmversion required
2 0 .3°0) 3 (5%)
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Table 2. Characteristics of 60 Inpatients and 60 Outpatients
Inpatients Outpatients
Age -1 17 . 17 17
--- 17
Gender 30 S
. 30 F
30 5l, 30 F
Hean d: o-
N- 46 46
CAD
7
7
CM 3
volwl .r
omer -
aeferring (iagm005
NSYT 13 13
SVT Is Is
Hean block I I
Syncope
14 H
Palpitation 6
6
WPW 12 12
aesuns or ; :PST
NOrmal 23
23
VT
0
He an block 3 0
sss
CSH
n
2 3a
SVT 24 32
Atriul fihri0anon 6 4
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Fgure 1. Mean costs associated with outpatient and inpatient
electrophysiologic testing . Physicians' fees are indicated by the solid
shading and hospital charges by the hatched regions . Although
physicians' fees were similar in the two groups, hospital charges
were far lower in the outpatient ($2,120 ± 1,244) than in the inpatient
group (55,645 ± 3,763; p < 0.101).
electrophysiologic studies performed in outpatients revealed
abnormal findings and led to new therapeutic interventions
.
Outpatient angiographic cardiac catheterization . Cardiac
catheterization has been performed in outpatient settings
since 1979 (8). Several studies (9-11) have demonstrated a
relatively low complication rate of outpatient cardiac cathe-
terization. In addition, avoiding the need for hospitalization
has resulted in a reduced cost . A recent randomized com-
parison of inpatient versus outpatient catheterization (12)
demonstrated no significant differences in the rate of com-
plications and a cost saving of $885 per patient in the
outpatient group
. In that series 12% of the patients assigned
to the outpatient group required hospitalization because of
complications .
Indications for electrophysiologic testing. The indications
for electrophysiologic testing have evolved significantly over
the past several years and a recent report of an American
College of Cardiology/American Heart Association Task
Force (4) has suggested a specific set of guidelines . These
recommendations include classes of indications for electro-
physiologic testing : class 1, in which there is general agree-
ment that electrophysiologic testing is indicated ; class 11, in
which opinion is divided as to whether testing is indicated ;
and class III, in which it is generally agreed that testing is not
warranted
. Many patients with indications for electrophysi-
ologic testing do not have life-threatening arrhythmias and
thus would be candidates for electrophysiologic testing as
outpatients
.
Although these guidelines more not available at the time
our studies were performed, the large majority of our pa-
JACC Vol . 16. No. 6
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tients met class I or II indications for electrophysiologic
testing. The largest groups of patients consisted
of those
with the Wolff-Parkinson-White syndrome and symptomatic
tachycardias who were undergoing studies for localization of
their accessory pathways, those with unexplained syncope
and those with symptomatic nonsustained ventricular tachy-
cardia. Seventy-five percent of the patients who underwent
outpatient electrophysiologic testing had no underlying
structural heart disease
. Thus, a large number of patients
who make up these groups and have appropriate indications
for electrophysiologic testing can have studies performed as
outpatients. However, they do represent a minority of
patients who undergo electrophysiologic testing in our labo-
rotory.
Complications and patient satisfaction. Although compli-
cations may occur during electrophysiologic testing, they are
generally less frequent and less severe than those that occur
during cardiac catheterization. None of the patients who
underwent outpatient electrophysiologic testing had a seri-
ous complication of any type. Two inpatients had complica-
tions, neither of which required therapeutic intervention .
Thus, outpatient electrophysiologic testing can be performed
safely .
No patient developed a proarrhythmic response to anti-
arrhythmic drugs in this study. However, such a risk could
exist in patients with structural heart disease who are given
a new antiarrhythmic agent as outpatients .
Only one outpatient reported a "problem" with the
electrophysiologic test, a tingling in the right leg . In addition,
the large majority of patients who underwent electrophysio-
logic testing as outpatients preferred this approach to hospi-
talization. Interestingly, most of the patients who underwent
the inpatient procedure expressed a preference for that
approach. This suggests that patient satisfaction is high
regardless of the setting of the electrophysiologic test .
Cost analysis. Pressures to reduce costs of medical care
have increased in recent years (13)
.
Performance of electro-
physiologic tests in outpatients resulted in a mean saving of
>93,500 per patient, which is far in excess of the cost saving
reported for outpatient cardiac catheterization (12) . Addi-
tional invasive studies performed during the hospitalization
were not responsible for this difference because these were
excluded from the cost analysis . Inpatients who had a
normal electrophysiologic test result were hospitalized dur-
ing telemetric electrocardiographic monitoring for up to 2
days, resulting in substantial cost. In addition, inpatients
who had an abnormal electrophysiologic test result remained
hospitalized for electrophatmacologic testing and the cost of
hospitalization during the intervening days was responsible
for a large part of the cost differential between inpatient and
outpatient testing .
Limitations. There are several limitations in the current
study . A total of only 100 outpatient electrophysiologic tests
were analyzed and, thus, the possibility of a slightly higher
JACC Vol . 1 6, No . 6
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complication rate during outpatient electrophysiologic test-
ing cannot be excluded with certainty . In addition, the
majority of patients who underwent outpatient electrophys-
iologic testing had no structural heart disease, reducing the
risk of a proarrhythmic response to a newly administered
antiarrhythmic agent (14) and allowing antiarrhythmic drug
therapy to be initiated safely after hospital discharge . Pa-
tients with structural heart disease and left ventricular dys-
function who are treated with a class I antiarrhythmic agent
as a result
of electrophysiologic testing may require hospi-
talization for monitoring of their drug therapy . Finally,
because the study was not randomized, the amount of cost
savings provided by outpatient electrophysiologic testing
may have been overestimated because of unapparent selec-
tion bias. Nonetheless, the large cost differential between
the two groups suggests that outpatient electrophysiologic
testing has a significant economic advantage over inpatient
testing.
Conclusions. We have demonstrated that electrophysio-
logic testing is feasible in an outpatient setting in patients
without life-threatening arrhythmias . These patients can be
safely sent home after 3 to 6 h of monitoring in a recovery
room. In addition, outpatient electrophysiologic testing re-
sults in significant cost savings. We conclude that outpatient
electrophysiologic testing is preferable to inpatient testing in
patients who do not have life-threatening arrhythmias .
We drank Bill S2bonya, Keith Childs and the Electrophysiclogy Laboratory
pusses, technicians and fellows for technical assistance and Marion Maguire
for secretarial help.
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